Dermapharm Holding SE DMPHF
$47.69
Last Updated: Jul 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
DMPHF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Dermapharm Holding SE is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Dermapharm Holding SE. Stock Analysis DMPHF
United States Health Care Mid Cap Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The firm operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. The company holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The firm offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. The company is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Dermapharm Holding SE (DMPHF) Chart
Financial Metrics & Statements of Dermapharm Holding SE (DMPHF)
FAQ's for Dermapharm Holding SE (DMPHF)
- As of August 2026, Dermapharm Holding SE DMPHF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Dermapharm Holding SE using these criteria to determine its compliance status.
- Muslim investors may consider investing in Dermapharm Holding SE if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Dermapharm Holding SE by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Dermapharm Holding SE may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Dermapharm Holding SE on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Dermapharm Holding SE (DMPHF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
